Debut Plus

₹36.5

▼ -0.47 -1.27%

17 Jul 2026

BSE Listed

Bacil Pharma Ltd. (524516)

Volume: 6,08,573Avg Vol 1W: 3,01,387Avg Vol 1M: 2,76,11852W Range:₹26.69₹61.8
BSE www.bacilpharma.co.in
Key Ratios
Checked just now
Market Cap₹52 Cr
Current Price₹36.5
Previous Close₹36.97
High / Low (52w)₹61.8 / ₹26.69
Volume6,08,573
Avg Vol (1W)3,01,387
Avg Vol (1M)2,76,118
Stock P/E33.8
Book Value₹17.55
Dividend Yield0%
ROE6.27%
ROA489.23%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹1.08
P/B2.08
Debt / Equity0.01
50 DMA₹46.1
200 DMA₹44.06
Day change-1.27%
Price Chart
₹36.5▼ 2.87% · 1Y
₹60₹2812.3L
2025-07-28
2026-07-17

20-day avg volume: 2.9L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 407% YoY.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹1 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-4 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹-4 Cr₹0 Cr₹0 Cr₹0 Cr₹-4 Cr₹0 Cr₹0 Cr₹0 Cr
EPS-6.37-0.58-0.54-0.41-6.55-0.17-0.10.64
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹1 Cr₹1 Cr₹1 Cr₹26 Cr
Total Liabilities₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Equity₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹25 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹-4 Cr₹0 Cr₹0 Cr₹0 Cr
Investing₹1 Cr₹4 Cr₹0 Cr₹0 Cr₹0 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹2 Cr
Free Cash Flow₹0 Cr₹-4 Cr₹0 Cr₹0 Cr₹0 Cr
Shareholding
Promoter 0% Institutions 0% Public 100%
Efficiency & Working Capital
ROCE4%
Interest Coverage0
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details

As of 2026-03-31

Promoter0%
FII0%
DII0%
Institutions0%
Public100%
Promoter Pledge—
No. of Shareholders7,226
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Jul 2025Sept 2025Dec 2025Mar 2026
Promoters42.7%42.7%42.7%42.7%20.7%10.6%0.2%0.2%0.1%0.1%0.1%0%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public57.3%57.3%57.3%57.3%79.3%89.4%99.8%99.8%99.9%99.9%99.9%100%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%—
No. of Shareholders6,6476,6286,7706,7946,9027,4617,6387,5327,5417,4317,4317,226
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Nikita Hiren PatelPublic Shareholding19.4%27,90,000
Manubhai Amrutlal ShahPublic Shareholding18.3%26,31,709
Vicky Pratapbhai ShahPublic Shareholding16.6%23,81,718
Chhaya Gaurang ShahPublic Shareholding6.4%9,21,499
Manmohan Jagdishprasad GhuwalewalaPublic Shareholding4.2%6,00,000
Navin Keshrimal MehtaPublic Shareholding2.2%3,11,801
Deepa Navin MehtaPublic Shareholding1.7%2,50,000
Hemang Rajendra DoshiPublic Shareholding1.7%2,45,251
Saroj Kishor MehtaPublic Shareholding1.2%1,65,861
Dhrumil Rakesh PatelPublic Shareholding1.1%1,50,379
Suman P ShahShareholding of Promoter and Promoter Group0%0
Gulecha Investment & Trading Co Pvt LtdShareholding of Promoter and Promoter Group0%0
Khem Sum Apparels Overseas LimitedShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Suman P Shah00%2026-03-31
Gulecha Investment & Trading Co Pvt Ltd00%2026-03-31
Khem Sum Apparels Overseas Limited00%2026-03-31
Dhrumil Rakesh Patel00%2026-03-31
Hemang Rajendra Doshi00%2026-03-31
Deepa Navin Mehta00%2026-03-31
Vicky Pratapbhai Shah00%2026-03-31
Manubhai Amrutlal Shah00%2026-03-31
Saroj Kishor Mehta00%2026-03-31
Navin Keshrimal Mehta00%2026-03-31
Manmohan Jagdishprasad Ghuwalewala00%2026-03-31
Nikita Hiren Patel00%2026-03-31
Board of Directors
NameDesignationYear
Chaitali Kalpataru ShahExecutive Director & CFO2025
Dinesh Chander NotiyalIndependent Non Exe. Director2025
Avani Savjibhai GodhaniyaIndependent Non Exe. Director2025
Vivek Mukesh YadavIndependent Non Exe. Director2025
Tak Bhavana TakCompany Sec. & Compli. Officer2025
Aayush ShahIndependent Director2025
Ankitkumar Surendrakumar AgrawalIndependent Director2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10201314
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-09Board Meetings—
Substantial Acquisitions (SAST)

30 disclosure(s)

Market10/06/2026 · 8,00,000
Market08/06/2026 - 09/06/2026 · 3,26,104
Off Market19/02/2026 · 20,75,000
Off Market19/02/2026 · 20,75,000
Off Market29/12/2025 · 200
Market24/12/2025 · 500
Company Information
Incorporated1987
AuditorLaxmikant Kabra & Co LLP
Investor Email[email protected]
🌐 www.bacilpharma.co.in ↗

📍 G2 & G3 Samarpan Complex, chakala Andheri East, Mumbai, Maharashtra, 400099

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Riddhi Siddhi Gluco BiolsSVC Industries LimitedRaaj Medisafe India Ltd.Revati Media LimitedCoral Laboratories Ltd.Tulasee Bio-Ethanol Ltd.Krebs Biochemicals & IndustriesKMC Speciality HospitalsLaffans Petrochemicals Ltd.Bhaskar Agrochemicals Ltd.Sukhjit Starch & ChemicalsSharma East India HospitaAll “52” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search